The NHS is set to trial a new breath test which uses artificial intelligence (AI) and operates at the ‘nanoparticles’ level to enable it to detect a range of diseases.

Innovative AI

The new ‘electronic nose’ technology looks for chemicals, or ‘biomarkers’, that are produced by a number of conditions, including cancer, dementia and tuberculous (TB). The new breath test is more sensitive, meaning it will therefore be more accurate, than ones which are currently being used.